ctDNA and immune biomarker testing for molecular residual disease surveillance and immune stratification in cancer

Ning Cui, Hongying Hao, Xiaofeng Hu, Yaxuan Li

Open source

DOI: 10.3389/fmed.2026.1942673
Published: 2026-09-09
Container: Frontiers in Medicine
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2026.1942673,
  title = {ctDNA and immune biomarker testing for molecular residual disease surveillance and immune stratification in cancer},
  author = {Ning Cui and Hongying Hao and Xiaofeng Hu and Yaxuan Li},
  year = {2026},
  journal = {Frontiers in Medicine},
  doi = {10.3389/fmed.2026.1942673},
  url = {https://doi.org/10.3389/fmed.2026.1942673}
}

RIS

TY  - JOUR
TI  - ctDNA and immune biomarker testing for molecular residual disease surveillance and immune stratification in cancer
AU  - Ning Cui
AU  - Hongying Hao
AU  - Xiaofeng Hu
AU  - Yaxuan Li
PY  - 2026
JO  - Frontiers in Medicine
DO  - 10.3389/fmed.2026.1942673
UR  - https://doi.org/10.3389/fmed.2026.1942673
ER  -

APA

Cui, N., Hao, H., Hu, X., & Li, Y. (2026). ctDNA and immune biomarker testing for molecular residual disease surveillance and immune stratification in cancer. Frontiers in Medicine. https://doi.org/10.3389/fmed.2026.1942673

Source records

crossref · retrieved 2026-09-25T08:53:50.683Z